Novel pyridazinone derivatives as inhibitors of CDK2

Details for Australian Patent Application No. 2005243493 (hide)

Owner Aventis Pharma S.A.

Inventors Matter, Hans; Will, David William; Schoenafinger, Karl; Mueller, Guenter; Hoelder, Swen

Agent Davies Collison Cave

Pub. Number AU-A-2005243493

PCT Pub. Number WO2005/111019

Priority 04011735.0 18.05.04 EP

Filing date 17 May 2005

Wipo publication date 24 November 2005

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

30 November 2006 PCT application entered the National Phase

  PCT publication WO2005/111019 Priority application(s): WO2005/111019

7 February 2008 Amendment Made

  The nature of the amendment is: Amend the names of the co-inventors to read Steinmetz, Anke; Matter, Hans; Will, David William; Schoenafinger, Karl; Bossart, Martin; Delaisi, Christine; Benard, Didier; Mueller, Guenter; Hoelder, Swen; Sassoon, Ingrid and Combeau, Cecile

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005243498-Polymer powder containing polyamide, use of said powder in a moulding method and moulded body produced from the same

2005243490-Methods and kits to detect hereditary angioedema type III